Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01267032 · ClinicalTrials.gov registry record · Phase 2

Helping Veterans Quit Smoking by Improving Their Sleep

A Phase 2 study, sponsored by US Department of Veterans Affairs.

Terminated
Registry status
Phase 2
Development phase
142
Enrollment target

NCT01267032 is a Phase 2 study that was terminated before completion, run by US Department of Veterans Affairs. The registered enrollment target is 142 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01267032, a Phase 2 study, was terminated before completion, sponsored by US Department of Veterans Affairs.

TERMINATED
Registry status
Phase 2
Development phase
142 participants
Enrollment target

Study Summary

This project is designed to determine whether an efficacious behavioral intervention for insomnia can improve the quit rates achieved by an efficacious smoking cessation program aimed at PTSD patients ("Integrated Care"). A second aim is to deepen our understanding of the mechanisms relating sleep and smoking in PTSD.

Interventions

  • BEHAVIORAL Integrated Care
  • BEHAVIORAL Desensitization Treatment for Insomnia
  • BEHAVIORAL Cognitive-Behavioral Treatment for Insomnia

Trial Details

FieldValue
Enrollment Target 142 participants
Start Date 2011-10
Est. Completion 2013-06
Phase Phase 2

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT01267032

The ClinicalTrials.gov registry entry for NCT01267032 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Integrated Care is the first listed.

NCT01267032 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01267032 about?

NCT01267032 is a clinical study titled "Helping Veterans Quit Smoking by Improving Their Sleep". This project is designed to determine whether an efficacious behavioral intervention for insomnia can improve the quit rates achieved by an efficacious smoking cessation program aimed at PTSD patients ("Integrated Care"). A second aim is to deepen our understanding of the mechanisms relating sleep a...

What is the current status of trial NCT01267032?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 142 participants. The study started on 2011-10. Estimated completion is 2013-06.

What interventions are being tested in trial NCT01267032?

The interventions under investigation include: Integrated Care (BEHAVIORAL), Desensitization Treatment for Insomnia (BEHAVIORAL), Cognitive-Behavioral Treatment for Insomnia (BEHAVIORAL).

Who is sponsoring clinical trial NCT01267032?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.